{"id":61245,"date":"2024-11-14T13:05:56","date_gmt":"2024-11-14T16:05:56","guid":{"rendered":"https:\/\/insurancecorp.com.br\/pt\/?p=61245"},"modified":"2024-11-14T13:05:56","modified_gmt":"2024-11-14T16:05:56","slug":"ans-promove-audiencia-publica-49","status":"publish","type":"post","link":"https:\/\/insurancecorp.com.br\/pt\/2024\/11\/14\/ans-promove-audiencia-publica-49\/","title":{"rendered":"ANS promove Audi\u00eancia P\u00fablica 49"},"content":{"rendered":"<p class=\"v1ql-align-justify\">A Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) vai realizar, em 22\/11, a Audi\u00eancia P\u00fablica 49 para debater a proposta de incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade das seguintes tecnologias:<\/p>\n<p class=\"v1ql-align-justify\">&#8211; Teste gen\u00e9tico para diagn\u00f3stico de diabetes tipo MODY, para pacientes diagnosticados com diabetes, com idade menor que 30 anos e com probabilidade de 40% em MODY calculator;<\/p>\n<p class=\"v1ql-align-justify\">&#8211; Enzalutamida em monoterapia, para o tratamento de c\u00e2ncer de pr\u00f3stata horm\u00f4nio-sens\u00edvel n\u00e3o-metast\u00e1tico em recorr\u00eancia bioqu\u00edmica de alto risco; e<\/p>\n<p class=\"v1ql-align-justify\">&#8211; Enzalutamida em combina\u00e7\u00e3o com leuprorrelina, para o tratamento de c\u00e2ncer de pr\u00f3stata horm\u00f4nio-sens\u00edvel n\u00e3o-metast\u00e1tico em recorr\u00eancia bioqu\u00edmica de alto risco.<\/p>\n<p class=\"v1ql-align-justify\">As tr\u00eas propostas tiveram recomenda\u00e7\u00e3o preliminar de n\u00e3o incorpora\u00e7\u00e3o \u00e0 lista de coberturas obrigat\u00f3rias pelos planos de sa\u00fade, tendo sido debatidas 34\u00aa reuni\u00e3o t\u00e9cnica da Comiss\u00e3o de Atualiza\u00e7\u00e3o do Rol de Procedimentos e Eventos em Sa\u00fade (Cosa\u00fade), realizada em 22 e 23\/10. Elas foram apresentadas durante a\u00a0<a href=\"https:\/\/www.youtube.com\/watch?v=Q5LIvEsxsJ0\" target=\"_blank\" rel=\"noopener noreferrer\">614\u00aa Reuni\u00e3o Extraordin\u00e1ria da Diretoria Colegiada (DICOL)<\/a>, realizada no dia 4\/11, quando foi aprovada a realiza\u00e7\u00e3o da audi\u00eancia p\u00fablica.<\/p>\n<p class=\"v1ql-align-justify\">As tecnologias tamb\u00e9m est\u00e3o recebendo contribui\u00e7\u00f5es atrav\u00e9s da Consulta P\u00fablica 143 at\u00e9 27\/11.\u00a0<a href=\"https:\/\/licitacoes.apps.sa-1a.mendixcloud.com\/link\/ConsultasPublicas\" target=\"_blank\" rel=\"noopener noreferrer\">Clique aqui<\/a>\u00a0para saber mais.<\/p>\n<p class=\"v1ql-align-justify\">O evento vai ocorrer de forma remota, pela plataforma Teams, com transmiss\u00e3o pelo YouTube, das 9h \u00e0s 12h.<\/p>\n<p class=\"v1ql-align-justify\">Para participar da Audi\u00eancia P\u00fablica 49, \u00e9 preciso fazer inscri\u00e7\u00e3o at\u00e9 as 17h do dia 21\/11,\u00a0<a href=\"https:\/\/www.ans.gov.br\/sisge\/cadastro\/default_sisge.asp?id=644\" target=\"_blank\" rel=\"noopener noreferrer\">clicando aqui.<\/a>\u00a0A grava\u00e7\u00e3o ficar\u00e1 dispon\u00edvel no site da Ag\u00eancia.<\/p>\n<p><a href=\"https:\/\/www.gov.br\/ans\/pt-br\/acesso-a-informacao\/participacao-da-sociedade\/audiencias-publicas\/audiencia-publica-no-49\" target=\"_blank\" rel=\"noopener noreferrer\">Clique aqui<\/a>\u00a0para conferir todos os documentos referentes a esta audi\u00eancia p\u00fablica, ou acesse o Portal da ANS e, no menu Acesso \u00e0 Informa\u00e7\u00e3o, entre na se\u00e7\u00e3o Participa\u00e7\u00e3o da Sociedade, item Audi\u00eancias P\u00fablicas.<\/p>\n<p><strong>Assessoria de imprensa da ANS<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) vai realizar, em 22\/11, a Audi\u00eancia P\u00fablica 49 para debater a proposta de incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade das seguintes tecnologias: &#8211; Teste gen\u00e9tico para diagn\u00f3stico de diabetes tipo MODY, para pacientes diagnosticados com diabetes, com idade menor que 30 anos e com probabilidade [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[380],"tags":[12759,779,8131,3509,5968],"jetpack_featured_media_url":"","yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v14.8 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ANS promove Audi\u00eancia P\u00fablica 49 | Revista Insurance Corp | PT-BR<\/title>\n<meta name=\"robots\" content=\"index, follow\" \/>\n<meta name=\"googlebot\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta name=\"bingbot\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/insurancecorp.com.br\/pt\/2024\/11\/14\/ans-promove-audiencia-publica-49\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ANS promove Audi\u00eancia P\u00fablica 49 | Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"og:description\" content=\"A Ag\u00eancia Nacional de Sa\u00fade Suplementar (ANS) vai realizar, em 22\/11, a Audi\u00eancia P\u00fablica 49 para debater a proposta de incorpora\u00e7\u00e3o ao Rol de Procedimentos e Eventos em Sa\u00fade das seguintes tecnologias: &#8211; Teste gen\u00e9tico para diagn\u00f3stico de diabetes tipo MODY, para pacientes diagnosticados com diabetes, com idade menor que 30 anos e com probabilidade [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/insurancecorp.com.br\/pt\/2024\/11\/14\/ans-promove-audiencia-publica-49\/\" \/>\n<meta property=\"og:site_name\" content=\"Revista Insurance Corp | PT-BR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-14T16:05:56+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Organization\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#organization\",\"name\":\"Revista Insurance Corp\",\"url\":\"https:\/\/insurancecorp.com.br\/pt\/\",\"sameAs\":[\"https:\/\/www.facebook.com\/RevistaInsuranceCorp\/\"],\"logo\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#logo\",\"inLanguage\":\"pt-BR\",\"url\":\"\",\"caption\":\"Revista Insurance Corp\"},\"image\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#logo\"}},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#website\",\"url\":\"https:\/\/insurancecorp.com.br\/pt\/\",\"name\":\"Revista Insurance Corp | PT-BR\",\"description\":\"A \\u00fanica revista bil\\u00edngue voltada ao mercado de seguro.\",\"publisher\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/insurancecorp.com.br\/pt\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2024\/11\/14\/ans-promove-audiencia-publica-49\/#webpage\",\"url\":\"https:\/\/insurancecorp.com.br\/pt\/2024\/11\/14\/ans-promove-audiencia-publica-49\/\",\"name\":\"ANS promove Audi\\u00eancia P\\u00fablica 49 | Revista Insurance Corp | PT-BR\",\"isPartOf\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#website\"},\"datePublished\":\"2024-11-14T16:05:56+00:00\",\"dateModified\":\"2024-11-14T16:05:56+00:00\",\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/insurancecorp.com.br\/pt\/2024\/11\/14\/ans-promove-audiencia-publica-49\/\"]}]},{\"@type\":\"Article\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2024\/11\/14\/ans-promove-audiencia-publica-49\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2024\/11\/14\/ans-promove-audiencia-publica-49\/#webpage\"},\"author\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af\"},\"headline\":\"ANS promove Audi\\u00eancia P\\u00fablica 49\",\"datePublished\":\"2024-11-14T16:05:56+00:00\",\"dateModified\":\"2024-11-14T16:05:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/2024\/11\/14\/ans-promove-audiencia-publica-49\/#webpage\"},\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#organization\"},\"keywords\":\"49,ans,audi\\u00eancia,promove,publica\",\"articleSection\":\"ANS\",\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/insurancecorp.com.br\/pt\/2024\/11\/14\/ans-promove-audiencia-publica-49\/#respond\"]}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#\/schema\/person\/1b69c8cf325f0b7167f1b171f52df4af\",\"name\":\"Publica\\u00e7\\u00e3o\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/insurancecorp.com.br\/pt\/#personlogo\",\"inLanguage\":\"pt-BR\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/17226f1f60486eb25d4c6b301ffed37f?s=96&d=mm&r=g\",\"caption\":\"Publica\\u00e7\\u00e3o\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/61245"}],"collection":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/comments?post=61245"}],"version-history":[{"count":2,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/61245\/revisions"}],"predecessor-version":[{"id":61247,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/posts\/61245\/revisions\/61247"}],"wp:attachment":[{"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/media?parent=61245"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/categories?post=61245"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/insurancecorp.com.br\/pt\/wp-json\/wp\/v2\/tags?post=61245"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}